27-29 June, 2016
The Marker San Francisco, San Francisco, CA
Senior Specialist, Quality, Vaccine and Biological Stability Merck
Ms. Gentile began her career with Merck in 1996. She started in the Merck Research Labs, developing analytical assays which were used to monitor the stability of pharmaceutical products. She then held positions of increasing responsibility in pharmaceutical, vaccines, and biologics stability groups, supporting both research and manufacturing areas. Today she is a Senior Specialist, Quality for Merck Vaccine and Biological Stability, where she is responsible for defining stability strategies for new and commercial vaccines and biologics. She has spent the past 10 years defining Merck's distribution strategy for pharmaceutical, vaccine, and biologics products from a stability perspective. Ms. Gentile holds a B.S. in Chemistry from The College of New Jersey (TCNJ) and an M.S. in Quality Assurance and Regulatory Affairs from Temple University. Ms. Gentile lives in PA with her husband and two sons.